United States · Bill · HR
H.R. 7383 (118th)
RARE Act
Introduced
15 February 2024
Last action
16 February 2024 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Matsui, Doris O. [D-CA-7], Rep. Bilirakis, Gus M. [R-FL-12], Richard Hudson
Subjects
Healthcare
Source updated
5 December 2025
Summary
Retaining Access and Restoring Exclusivity Act or the RARE Act This bill specifies that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drug exclusivity period) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. Current law grants a seven-year period of market exclusivity for an approved orphan drug, during which the Food and Drug Administration (FDA) may not approve an application from another manufacturer for the same drug for the same disease or condition. The FDA's regulations provide that this exclusivity is specific to the same approved use or indication of the drug, rather than all uses or indications, for the disease or condition. However, in Catalyst Pharmaceuticals, Inc. v. Becerra, a court held that exclusivity did extend to all uses or indications for the disease or condition. The bill provides statutory authority for the FDA's regulations.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
15 February 2024
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
15 February 2024
Introduced
Introduced in House
Source: IntroReferral
15 February 2024
Introduced
Introduced in House
Source: IntroReferral
16 February 2024
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 15 February 2024 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 15 February 2024
Introduced in House (PDF)
Introduced in House · EN · 15 February 2024
Introduced in House
summary · EN · 15 February 2024
Sponsors
- Rep. Matsui, Doris O. [D-CA-7] · D · Sponsor
- Rep. Bilirakis, Gus M. [R-FL-12] · R · Sponsor
- Richard Hudson · R · Cosponsor
- · hsif00 · Standing
Related records
- related to → Give Kids a Chance Act of 2024
- related to → RARE Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/7383
- Open data entity: https://api.congress.gov/v3/bill/118/hr/7383
- us · 118-hr-7383 · source updated 5 December 2025